VanishPoint syringes have been called "the gold standard for retractable needle syringes."* They are available in a variety of sizes (0.5, 1, 3, 5, and 10mL), needle gauges, and needle lengths. The needle is automatically retracted directly from the patient into the barrel of the syringe when the plunger handle is fully depressed. The pre-removal, automated retraction virtually eliminates exposure to the contaminated needle, effectively reducing the risk of needlestick injury.
VanishPoint syringes are easy to use, require no additional steps, and allow for single-handed activation. After activation, they require less disposal space than most other safety needles/syringes and prevent disposal-related needlestick injuries.
Patient Safe syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. They protect both the patient and the clinician and are available in a variety of sizes.
The innovative luer guard design promotes safe handling of syringe and medication by reducing the risk of luer tip contact contamination. Plus, they are compatible with most available hypodermic needles.
NEW EasyPoint retractable needles feature automated retraction technology and pre-removal capability that has made Retractable Technologies the industry standard, but with added versatility. They can be used with luer lock and luer slip syringes, including pre-filled syringes. When the color-coded activation tab is pressed, the needle automatically retracts into the safety chamber and remains enclosed through disposal. Upon needle retraction, the syringe luer tip is covered, reducing the risk of exposure to medication or blood and body fluids. EasyPoint retractable needles are easy to use, allowing single-handed activation, while the clinician's fingers remain behind the exposed sharp at all times.
In 1989, Retractable's founder, Thomas J. Shaw, saw a television news segment about a doctor who had contracted HIV from an accidental needlestick injury. The doctor complained that design engineers were insensitive and unresponsive to the dangers faced daily by frontline healthcare workers.
Shaw, a mechanical and structural engineer, was struck by the doctor's criticism and felt compelled to act. After spending a year developing preliminary design concepts, Shaw was awarded a grant by the National Institute on Drug Abuse, a subsidiary of the National Institutes of Health (NIH), to further develop his design concepts. Later he was awarded an additional grant to commercialize the production of one of his retractable syringe designs and to produce products for clinical trials.